Skip to main content

Find Clinical Trials

Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,144 public trials 77 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C

NCT00122616

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +23 more
Locations: Service de Maladies Infectieuses et de Réanimation Médicale Rennes, France

View Trial Details

Completed

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

NCT00926614

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Brooke Army Medical Center San Antonio, Texas, United States

View Trial Details

Completed

The Effects of Mogroside Sweetener on Viral Load in TreatmenT Naive Genotype 1 (GT 1) Subjects CHC

NCT00926120

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Brooke Army Medical Center San Antonio, Texas, United States

View Trial Details

Completed

Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin

NCT00207402

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +13 more
Locations: Brooke Army Medical Center Fort Sam Houston, Texas, United States

View Trial Details

Completed

Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC

NCT00207363

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Brooke Army Medical Center Fort Sam Houston, Texas, United States

View Trial Details

Completed

Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

NCT00926016

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Brooke Army Medical Center San Antonio, Texas, United States

View Trial Details

Completed

Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus

NCT00207311

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Brooke Army Medical Center Fort Sam Houston, Texas, United States

View Trial Details

Completed

Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 Infection

NCT01273948

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: LTD Vakhtang Bochorishvili Anticeptic Centre Tbilisi, Georgia

View Trial Details

Completed

A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1

NCT01247194

Conditions: Blood-Borne Infections, Chronic Genotype 1 Hepatitis C Virus Infection, Communicable Diseases, +9 more
Locations: Local Institution Sacramento, California, United States

Local institution San Francisco, California, United States

Local institution Aarhus, Denmark

Local institution Copenhagen, Denmark

View Trial Details

Completed

Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV

NCT00863239

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: eStudy site Chula Vista, California, United States

eStudy Site Oceanside, California, United States

Medical Associates Research Group San Diego, California, United States

University of Louisville Health Care Outpatient Center Louisville, Kentucky, United States

View all 24 locations

View Trial Details